Biosimilars: What HR Leaders Need to Know in 5 Minutes
If we had five minutes between meetings, here’s what I’d share: biosimilars are no longer a maybe. They’re a practical way to protect your budget and keep care steady for your people.
Entries by Kyrstin Hensley
GLP-1s in 2026: Fund Access, Protect Outcomes, Avoid the Blank Check
If you manage employer benefits, you’re staring at a 2026 puzzle: demand for GLP-1 medications keeps climbing while prices remain elevated, and oral options may expand utilization further.
The Weight Loss Benefit Cost Paradox: What HR Leaders Need to Know
They promise weight loss. But without a plan, GLP-1s can quietly become your biggest prescription care expense.